GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BetterLife Pharma Inc (FRA:NPAU) » Definitions » Asset Turnover

BetterLife Pharma (FRA:NPAU) Asset Turnover : 0.00 (As of Jul. 2024)


View and export this data going back to 2018. Start your Free Trial

What is BetterLife Pharma Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. BetterLife Pharma's Revenue for the three months ended in Jul. 2024 was €0.00 Mil. BetterLife Pharma's Total Assets for the quarter that ended in Jul. 2024 was €0.42 Mil. Therefore, BetterLife Pharma's Asset Turnover for the quarter that ended in Jul. 2024 was 0.00.

Asset Turnover is linked to ROE % through Du Pont Formula. BetterLife Pharma's annualized ROE % for the quarter that ended in Jul. 2024 was 52.70%. It is also linked to ROA % through Du Pont Formula. BetterLife Pharma's annualized ROA % for the quarter that ended in Jul. 2024 was -917.67%.


BetterLife Pharma Asset Turnover Historical Data

The historical data trend for BetterLife Pharma's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BetterLife Pharma Asset Turnover Chart

BetterLife Pharma Annual Data
Trend Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24
Asset Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

BetterLife Pharma Quarterly Data
Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of BetterLife Pharma's Asset Turnover

For the Biotechnology subindustry, BetterLife Pharma's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BetterLife Pharma's Asset Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BetterLife Pharma's Asset Turnover distribution charts can be found below:

* The bar in red indicates where BetterLife Pharma's Asset Turnover falls into.



BetterLife Pharma Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

BetterLife Pharma's Asset Turnover for the fiscal year that ended in Jan. 2024 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Jan. 2024 )/( (Total Assets (A: Jan. 2023 )+Total Assets (A: Jan. 2024 ))/ count )
=0/( (0.052+0.222)/ 2 )
=0/0.137
=0.00

BetterLife Pharma's Asset Turnover for the quarter that ended in Jul. 2024 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Jul. 2024 )/( (Total Assets (Q: Apr. 2024 )+Total Assets (Q: Jul. 2024 ))/ count )
=0/( (0.54+0.303)/ 2 )
=0/0.4215
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


BetterLife Pharma  (FRA:NPAU) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

BetterLife Pharma's annulized ROE % for the quarter that ended in Jul. 2024 is

ROE %**(Q: Jul. 2024 )
=Net Income/Total Stockholders Equity
=-3.868/-7.339
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-3.868 / 0)*(0 / 0.4215)*(0.4215/ -7.339)
=Net Margin %*Asset Turnover*Equity Multiplier
= %*0*-0.0574
=ROA %*Equity Multiplier
=-917.67 %*-0.0574
=52.70 %

Note: The Net Income data used here is four times the quarterly (Jul. 2024) net income data. The Revenue data used here is four times the quarterly (Jul. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

BetterLife Pharma's annulized ROA % for the quarter that ended in Jul. 2024 is

ROA %(Q: Jul. 2024 )
=Net Income/Total Assets
=-3.868/0.4215
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-3.868 / 0)*(0 / 0.4215)
=Net Margin %*Asset Turnover
= %*0
=-917.67 %

Note: The Net Income data used here is four times the quarterly (Jul. 2024) net income data. The Revenue data used here is four times the quarterly (Jul. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


BetterLife Pharma Asset Turnover Related Terms

Thank you for viewing the detailed overview of BetterLife Pharma's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


BetterLife Pharma Business Description

Traded in Other Exchanges
Address
1275 West 6th Avenue, Suite 300, Vancouver, BC, CAN, V6H 1A6
BetterLife Pharma Inc a biotechnology company, engages in the development and commercialization of psychedelic products for the treatment of mental disorders in Canada, the United States, Australia, and the European Union. It is involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections, such as coronavirus disease and human papillomavirus, and/or to directly inhibit tumors to treat various types of cancer.

BetterLife Pharma Headlines

No Headlines